ENDONOVO THERAPEUTICS, INC. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ENDONOVO THERAPEUTICS, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2022-06-30 was $115.20K, a 1.15% decline year-over-year.
- ENDONOVO THERAPEUTICS, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2022-03-31 was $88.80K, a 89.34% decline year-over-year.
- ENDONOVO THERAPEUTICS, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2021-09-30 was $126.46K.
- ENDONOVO THERAPEUTICS, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2021-06-30 was $116.55K, a 92396.83% increase year-over-year.
- ENDONOVO THERAPEUTICS, INC. stock issued during period, value, conversion of convertible securities for fiscal 2020 was $125.00.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2022-06-30 | $115.20K 10-Q · filed 2022-11-21 | |
| 2022-03-31 | $88.80K 10-Q · filed 2022-11-21 | |
| 2021-09-30 | $126.46K 10-Q · filed 2022-11-21 | |
| 2021-06-30 | $116.55K 10-Q · filed 2022-11-21 | |
| 2021-03-31 | $833.20K 10-Q · filed 2022-11-21 | |
| 2020-12-31 | $125.00 10-K · filed 2022-04-14 | |
| 2020-06-30 | $126.00 10-Q · filed 2021-11-19 |